Mural

Theta Lake Breaks New Ground in Unified Compliance Coverage for Unified Communication Platforms

Retrieved on: 
Monday, March 25, 2024
Data Management, Mobile, Wireless, Technology, Telecommunications, Software, Theta, Cloud, Online, City centre, Organization, Communication, Videotelephony, Partnership, Mural, RingCentral, SMS, AWS, PKCS, OEM, Miro, DCG, Visual Communications, UCC, UI, Human

The release showcases advancements in Voice, SMS, Whiteboards, Visual Collaboration, and Theta Lake’s extensive coverage across the spectrum of today’s top communication and collaboration platforms.

Key Points: 
  • The release showcases advancements in Voice, SMS, Whiteboards, Visual Collaboration, and Theta Lake’s extensive coverage across the spectrum of today’s top communication and collaboration platforms.
  • Theta Lake offers a flexible suite of capabilities that address compliance capture, recordkeeping, unified search, and storage across various communication tools and modalities.
  • Unified and certified compliance coverage for the most products and communication modalities in the Zoom platform suite, with the ability to enable, configure, and manage Theta Lake compliance functionality within the Zoom UI.
  • Broadening Collaboration Compliance Coverage: Theta Lake is excited to announce a new partnership with Miro and integrated coverage for Miro Enterprise Guard and Zoom Online Whiteboard , further expanding its collaboration compliance coverage.

Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting

Retrieved on: 
Tuesday, March 5, 2024
Cancer, Mural, AACR, Patient

DUBLIN, Ireland, March 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced two upcoming poster presentations at the American Association for Cancer Research (AACR) annual meeting taking place April 5-10 in San Diego.

Key Points: 
  • DUBLIN, Ireland, March 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced two upcoming poster presentations at the American Association for Cancer Research (AACR) annual meeting taking place April 5-10 in San Diego.
  • The presentations will be the first time Mural will share preclinical data from its IL-18 and IL-12 programs.
  • The details are as follows:
    All posters will be made available at https://www.muraloncology.com/publications/ following the presentations.

GE HealthCare to Spotlight Industry-Leading AI-Enabled Portfolio and Digital Solutions at HIMSS 2024

Retrieved on: 
Thursday, March 7, 2024
Data Management, Practice Management, Technology, Managed Care, General Health, Data Analytics, Other Health, Mobile, Wireless, Radiology, Medical Devices, Health Technology, Professional Services, Cardiology, Asset Management, Artificial Intelligence, Software, Health, Networks, Wearables, Mobile Technology, Hardware, Cloud, Anesthesiology, Hospital, Capacity, Artificial intelligence, HIMSS, Future, ADT, Organization, Atrial fibrillation, Command center, PACS, EMR, Atmosphere of Earth, Portrait, Google Images, AWS, Caption, Digital, Conference, Health information management, Foundation models, Potential, Workflow, Acquisition, Caregiver, AI, FDA, Food, Risk, Exhibition, Patient, GE HealthCare, Mural, Medical device

"At GE HealthCare, we understand the critical challenges healthcare providers face, from staffing shortages to complex workflows.

Key Points: 
  • "At GE HealthCare, we understand the critical challenges healthcare providers face, from staffing shortages to complex workflows.
  • At HIMSS 2024, GE HealthCare will be exhibiting the following medical devices and digital solutions:
    App Orchestrator: App Orchestrator, an application orchestration solution, gives customers easy access to multiple apps from multiple companies.
  • At HIMSS 2024, AWS will be in the GE HealthCare booth to support exploring these solutions.
  • Verisound: Verisound is GE HealthCare’s full suite of Digital and AI solutions, inclusive of reporting, fleet management, and collaboration tools.

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Retrieved on: 
Monday, February 26, 2024
Hospital, Algorithm, FDA, Digital, Safety, Length of stay, Health, Patient, Banerjee, GE HealthCare, Mural, Workforce, Command center

CHICAGO and BOSTON, Feb. 26, 2024 /PRNewswire/ -- GE HealthCare (Nasdaq: GEHC) and Biofourmis have announced a strategic collaboration aimed at enhancing continuity of care by enabling safe, effective, and accessible care in the home to support the patient journey beyond the hospital setting. The collaboration leverages the combined expertise of two market leaders to scale and deliver innovative care-at-home solutions.

Key Points: 
  • "Biofourmis' demonstrated success with care-at-home solutions will extend GE HealthCare's current inpatient monitoring portfolio to support patient care from the hospital to home," said Ashutosh Banerjee, GE HealthCare.
  • GE HealthCare's FlexAcuity™ monitoring solutions in combination with GE HealthCare's virtual care solutions like Mural ICU, Command Center and Digital CMU adapt to rapidly changing patient needs in the hospital and are built on a legacy of innovation.
  • By offering Biofourmis' virtual care-at-home solutions to customers, GE HealthCare can extend the care continuum beyond the hospital, and care teams can have a longitudinal patient view beyond the hospital setting.
  • GE HealthCare will begin distributing Biofourmis solutions to customers in the United States starting Q1 2024.

Enterprise Connect 2024 Announces Finalists for Best of Enterprise Connect Industry Awards

Retrieved on: 
Monday, February 26, 2024
VoIP, Software, Mobile, Wireless, Networks, Professional Services, Internet, Hardware, Apps, Applications, Technology, Artificial Intelligence, Audio, Video, Consulting, Telecommunications, Theta, CX, RingCentral, Slack, Monday.com, Microsoft, Enterprise, NexGen, AI, Human, Machine learning, Mural, Asana, Shure, Microsoft Teams, Zoom, Cisco, Cisco Webex, Exhibition, Vonage, Upwork, AV, Amazon Web Services, Sales

Enterprise Connect , the leading conference and exhibition for enterprise communications and customer experience, today announces the finalists for the Best of Enterprise Connect 2024 awards program.

Key Points: 
  • Enterprise Connect , the leading conference and exhibition for enterprise communications and customer experience, today announces the finalists for the Best of Enterprise Connect 2024 awards program.
  • Best of Enterprise Connect recognizes excellence and innovation in the enterprise communications and collaboration industry.
  • Finalists for the Best of Enterprise Connect awards are:
    MiaRec: MiaRec Automated Quality Management and Coaching, which uses generative AI technology to automatically score, summarize, and categorize 100 percent of contact center calls.
  • The exciting capabilities displayed by the innovative products that made the Best of Enterprise Connect finalists show the potential that AI and other cutting-edge technologies have for transforming enterprise communications and CX,” said Eric Krapf, General Manager, Enterprise Connect.

FlatFrog announces the launch of TeamTablet™ appliance family that ushers in the next generation of advancement for collaboration solutions

Retrieved on: 
Wednesday, January 24, 2024
Room, OLED, Long COVID, Mural, Partnership, Autodesk, Software, Microsoft Excel, Flex, Cisco Webex, System, PDF, Television

LUND, Sweden, Jan. 24, 2024 /PRNewswire/ -- Post-Covid, there has been considerable advancement in integrating video conferencing into meeting spaces. However, users continue to seek more engaging and collaborative experiences that go beyond video and audio calls afforded by current solutions.

Key Points: 
  • LUND, Sweden, Jan. 24, 2024 /PRNewswire/ -- Post-Covid, there has been considerable advancement in integrating video conferencing into meeting spaces.
  • However, users continue to seek more engaging and collaborative experiences that go beyond video and audio calls afforded by current solutions.
  • FlatFrog is thrilled to unveil the next wave of innovation, enabling IT to future-proof their meeting rooms with TeamTablet™Flex and TeamTablet™55 appliances.
  • Prepare to be amazed by its exceptional thin and light industrial design and built-in cloud enabled collaboration software features.

FlatFrog announces the launch of TeamTablet™ appliance family that ushers in the next generation of advancement for collaboration solutions

Retrieved on: 
Wednesday, January 24, 2024
Room, OLED, Long COVID, Mural, Partnership, Autodesk, Software, Microsoft Excel, Flex, Cisco Webex, System, PDF, Television

LUND, Sweden, Jan. 24, 2024 /PRNewswire/ -- Post-Covid, there has been considerable advancement in integrating video conferencing into meeting spaces. However, users continue to seek more engaging and collaborative experiences that go beyond video and audio calls afforded by current solutions.

Key Points: 
  • LUND, Sweden, Jan. 24, 2024 /PRNewswire/ -- Post-Covid, there has been considerable advancement in integrating video conferencing into meeting spaces.
  • However, users continue to seek more engaging and collaborative experiences that go beyond video and audio calls afforded by current solutions.
  • FlatFrog is thrilled to unveil the next wave of innovation, enabling IT to future-proof their meeting rooms with TeamTablet™Flex and TeamTablet™55 appliances.
  • Prepare to be amazed by its exceptional thin and light industrial design and built-in cloud enabled collaboration software features.

Mural Oncology Announces Enhancements to Late-Stage Clinical Trials

Retrieved on: 
Monday, January 8, 2024
IO, Protein engineering, Mural, Interleukin, Thought, Cancer, Patient, OS, PFS

DUBLIN, Ireland, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, announced strategic changes to its ARTISTRY-6 and ARTISTRY-7 clinical trials designed to generate more meaningful clinical data for these late-stage, potentially registrational trials of nemvaleukin.

Key Points: 
  • Mural plans to increase the size of this cohort by approximately 16 patients (to a total of approximately 90 patients) and expects a top-line data readout in the first half of 2025.
  • ARTISTRY-7 is a potentially registrational, phase 3 trial evaluating nemvaleukin as a monotherapy and in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.
  • Mural is also advancing engineered therapies targeting interleukin-18 and interleukin-12, with plans to nominate development candidates for each program in 2024.
  • The Company’s cash resources of $275 million, as of November 15, 2023, are expected to fund its operations into 4Q 2025.

Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies

Retrieved on: 
Wednesday, November 15, 2023
Rubius, IL-2, Mural, Cytokine, Research, General counsel, Alexion, Therapy, Head, Arbutus Biopharma, Jazz Pharmaceuticals, Patient, Doctor of Philosophy, Protein engineering, Bristol Myers Squibb, Pembrolizumab, IL-12, Alkermes (company), Halozyme, AbbVie, MBA, YM Biosciences, El Rubius, Nivolumab, Ipilimumab, ImClone Systems, Mirati Therapeutics, BMS, Financial toxicity, Mucosal melanoma, FRCP, The Celator, Cancer, PROC, GSK plc, Pharmaceutical industry, Vaccine, Management, Exelixis, Merck, Immunogen

DUBLIN, Ireland, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA) today launched as an independent, publicly traded, clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Mural’s ordinary shares will begin trading on the Nasdaq Global Market tomorrow, November 16th, under the ticker symbol “MURA”.

Key Points: 
  • “Immunotherapies have made a tremendous impact on the treatment of cancers over the past decade,” said Caroline Loew, Ph.D., the Company’s chief executive officer.
  • We believe Mural Oncology can lead the future of immunotherapies for patients.
  • Our protein engineering expertise allows us to reimagine the development of pro-inflammatory cytokine-based therapeutics that could address the key limitations with current cancer immunotherapies.
  • Goodwin Procter LLP and Arthur Cox LLP are serving as legal counsel to Mural Oncology.

OAAA ANNOUNCES 82ND OBIE AWARDS JURY

Retrieved on: 
Monday, December 11, 2023
Dentsu, Food, Transit, Entrepreneurship, HUGE, Contextual, Network-Integrated Multimedia Middleware, Creative, Culture, Marketing, Advertising, Digital, Fashion, Film, Strategy, Local, Holography, Digital design, Copywriting, Direct, SVP, Inside Looking Out (film), 3D, Street furniture, OOH, OAAA OBIE Awards, Billboard, Management, Photography, Mural, Health care

"This year's juror panel of seasoned industry executives are moving our industry forward day in and day out through their exemplary work and leadership. Their collective experience and award-winning careers make them the perfect group to gauge what creative excellence looks like in the OOH advertising space today," said Anna Bager, President & CEO of OAAA. "We expect to see entries that have leaned more heavily into emerging tech and taken more creative risks -- putting innovation front and center. I look forward to seeing what campaigns and executions rise to the top of the heap."

Key Points: 
  • WASHINGTON, Dec. 11, 2023 /PRNewswire/ -- The Out of Home Advertising Association of America (OAAA), the leading trade group representing the entire out of home (OOH) advertising industry, today announced the distinguished panel of jurors for the 82nd OBIE Awards, the oldest and most prestigious honors for creative excellence in OOH advertising design and execution.
  • Their collective experience and award-winning careers make them the perfect group to gauge what creative excellence looks like in the OOH advertising space today," said Anna Bager, President & CEO of OAAA.
  • Craft awards will be given in categories that include Copywriting, Digital Design, Photography, and more.
  • To learn more about the OBIE Awards and to enter, visit obieawards.org.